Home › Funds › Artia Global Partners LP › RXRX
Artia Global Partners LP position in RXRX
RECURSION PHARMACEUTICALS IN · Health Care
Artia Global Partners LP reported holding 334,402 shares of RXRX (RECURSION PHARMACEUTICALS IN) in its Q3 2026 13F filing — a position valued at US$1.4M, representing 0.28% of its reported portfolio and ranking #43 among its reported holdings. Artia Global Partners LP first reported this position in Q3 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Artia Global Partners LP's RXRX position evolved
Artia Global Partners LP first disclosed a stake in RXRX in Q3 2026 at 334,402 shares (US$1.4M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 334.40K | $1.38M | New |
About RXRX and 13F data
RXRX (RECURSION PHARMACEUTICALS IN) is a Health Care company. 29 other funds we track also report a position in RXRX — the largest reported positions include ARK Invest (US$184.8M), SOFTBANK GROUP CORP. (US$56.3M), MIC Capital Management UK LLP (US$34.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RXRX
- ARK Invest 44.75M sh · $184.80M · Q3 2026
- SOFTBANK GROUP CORP. 13.64M sh · $56.32M · Q3 2026
- MIC Capital Management UK LLP 8.26M sh · $34.09M · Q3 2026
- Data Collective IV GP, LLC 5.94M sh · $21.80M · Q2 2026
- GMT CAPITAL CORP 4.86M sh · $20.06M · Q3 2026
- DCVC Opportunity Fund II GP, LLC 3.95M sh · $14.50M · Q2 2026
- IQ EQ FUND MANAGEMENT (IRELAND) Ltd 2.68M sh · $11.06M · Q3 2026
More on Artia Global Partners LP
FAQ
How long has Artia Global Partners LP held RXRX?
Artia Global Partners LP has disclosed RXRX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Artia Global Partners LP's current position in RXRX?
As of Q3 2026, Artia Global Partners LP holds 334.40K shares of RXRX (RECURSION PHARMACEUTICALS IN), valued at $1.38M, representing 0.28% of its reported portfolio and ranking #43.
Has Artia Global Partners LP been buying or selling RXRX?
In the latest 13F filing (Q3 2026), Artia Global Partners LP newly opened its position in RXRX.
Which other funds hold RXRX?
Other major institutional holders of RXRX include ARK Invest, SOFTBANK GROUP CORP., MIC Capital Management UK LLP, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.